Semaglutide
OBES1TY
Novo Nordisk · Phase 3 · Not yet recruiting · Enrollment 122
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide | Obesity + T2D | n/r | n/r | n/r | n/r |
| Semaglutide placebo | Obesity + T2D | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Semaglutide
Novo Nordisk · Phase 3 · Not yet recruiting · Enrollment 122
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide | Obesity + T2D | n/r | n/r | n/r | n/r |
| Semaglutide placebo | Obesity + T2D | n/r | n/r | n/r | n/r |